Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06651333 · ClinicalTrials.gov registry record
fMRI and Opioid Abstinence
A clinical trial of Opioid Use and Opioid-Related Disorders, sponsored by Yale University.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT06651333: Recruiting study of Opioid Use and Opioid-Related Disorders, sponsored by Yale University.
NCT06651333 is a study of Opioid Use and Opioid-Related Disorders that is actively recruiting participants, run by Yale University. The registered enrollment target is 240 participants, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06651333, a study of Opioid Use and Opioid-Related Disorders, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.
Primary Outcome
Defined as the percent days of self-reported use of illicit opioids (assessed at monthly visits for 6-months following neuroimaging), with the exception of primary type of MOUD (i.e., methadone for methadone treated individuals, buprenorphine for buprenorphine treated individuals).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST fMRI
Study Locations (1)
Connecticut
- The APT Foundation - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2029-11 |
What NCT06651333 shows while recruiting
NCT06651333 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which fMRI is the first listed.
NCT06651333 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06651333 about?
NCT06651333 is a clinical study titled "fMRI and Opioid Abstinence". This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.
What is the current status of trial NCT06651333?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2024-12-12. Estimated completion is 2029-11.
What conditions does trial NCT06651333 study?
This clinical trial studies the following conditions: Opioid Use, Opioid-Related Disorders, Opioid Dependence, Opioid Abuse, Drug Use Disorder.
What interventions are being tested in trial NCT06651333?
The interventions under investigation include: fMRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06651333?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06651333 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06651333's enrollment target sits among peer trials
240 34th of 105 higher than 70 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Opioid Use After Laparoscopic Salpingectomy
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI